Formosa Laboratories, Inc.

Taiwan Stock Exchange 4746.TW

Formosa Laboratories, Inc. Free Cash Flow for the year ending December 31, 2023: USD 9.32 M

Formosa Laboratories, Inc. Free Cash Flow is USD 9.32 M for the year ending December 31, 2023, a 40.66% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Formosa Laboratories, Inc. Free Cash Flow for the year ending December 31, 2022 was USD 6.63 M, a 190.62% change year over year.
Formosa Laboratories, Inc. Free Cash Flow for the year ending December 31, 2021 was USD -7.31 M, a 61.65% change year over year.
Formosa Laboratories, Inc. Free Cash Flow for the year ending December 31, 2020 was USD -19.06 M, a 49.60% change year over year.
Formosa Laboratories, Inc. Free Cash Flow for the year ending December 31, 2019 was USD -37.82 M, a -6.91% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Taiwan Stock Exchange: 4746.TW

Formosa Laboratories, Inc.

CEO	Dr. Chen-Yu Cheng Ph.D.
IPO Date	Feb. 28, 2011
Location	Taiwan
Headquarters	36 Hoping Street
Employees	867
Sector	Health Care
Industries Pharmaceuticals

Description

Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.

Key trends

Past 5 years